Source:http://linkedlifedata.com/resource/pubmed/id/10050867
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1999-3-9
|
pubmed:abstractText |
Most human female cells contain two X chromosomes, only one of which is active. The process of X-chromosome inactivation, which occurs early in development, is usually random, producing tissues with equal mixtures of cells having active X chromosomes of either maternal or paternal origin. However, nonrandom inactivation may occur in a subset of females. If a tumor suppressor gene were located on the X chromosome and if females with a germline mutation in one copy of that suppressor gene experienced nonrandom X-chromosome inactivation, then some or all of the tissues of such women might lack the wild-type suppressor gene function. This scenario could represent a previously unrecognized mechanism for development of hereditary cancers. We investigated whether such a mechanism might contribute to the development of hereditary ovarian cancers.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0027-8874
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
339-46
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10050867-Case-Control Studies,
pubmed-meshheading:10050867-DNA, Neoplasm,
pubmed-meshheading:10050867-Dosage Compensation, Genetic,
pubmed-meshheading:10050867-Evolution, Molecular,
pubmed-meshheading:10050867-Female,
pubmed-meshheading:10050867-Genes, BRCA1,
pubmed-meshheading:10050867-Germ-Line Mutation,
pubmed-meshheading:10050867-Humans,
pubmed-meshheading:10050867-Loss of Heterozygosity,
pubmed-meshheading:10050867-Methylation,
pubmed-meshheading:10050867-Ovarian Neoplasms
|
pubmed:year |
1999
|
pubmed:articleTitle |
Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
|
pubmed:affiliation |
Department of Pharmacology, The University of Iowa Hospitals and Clinics, Iowa City 52242-1009, USA. richard-buller@uiowa.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|